Table 1.
Variables | Hazard Ratio | Std. Err. | p | [95% Conf. Interval] | |
---|---|---|---|---|---|
Gender (male vs. female) | 0.752 | 0.231 | 0.219 | 0.478 | 1.184 |
Age (<60 vs. ≥60) | 1.333 | 0.262 | 0.274 | 0.797 | 2.229 |
clinical stage (I–II vs. III–IV) | 5.575 | 0.223 | <0.001 * | 3.599 | 8.637 |
ECOG score (<2 vs. ≥2) | 3.960 | 0.211 | <0.001 * | 2.618 | 5.991 |
circKIF4 (high expression vs. low expression) | 0.606 | 0.208 | 0.016 * | 0.403 | 0.912 |
LDH (<60U/L vs ≥60U/L) | 2.962 | 0.210 | <0.001 * | 1.964 | 4.466 |
B symptoms (positive vs. negative) | 1.379 | 0.210 | 0.122 | 0.918 | 2.073 |
regional lymph nodes invasion (negative vs. positive) | 1.962 | 0.245 | 0.001 * | 1.299 | 2.964 |
Multivariate analysis | |||||
clinical stage (I–II vs. III–IV) | 1.747 | 0.290 | 0.055 | 0.989 | 3.084 |
ECOG score (<2 vs. ≥2) | 1.166 | 0.296 | 0.603 | 0.654 | 2.081 |
circKIF4 (high expression vs. low expression) | 0.500 | 0.223 | 0.002 * | 0.323 | 0.774 |
LDH (<60U/L vs ≥60U/L) | 0.741 | 0.232 | 0.196 | 0.471 | 1.167 |
regional lymph nodes invasion (negative vs. positive) | 0.000 | 52.764 | 0.803 | 0.001 | 1.577 |
Abbreviations: OS: overall survival; ECOG: eastern cooperative oncology group; LDH: lactate dehydrogenase.* indicates p < 0.05.